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ABSTRACT 
 
A series of some 1,ω-bis[4-carboxy/methoxycarbonyl/(hydrazinecarbonyl)/phenoxy]alkanes were 
synthesized and evaluated for their antimicrobial activity against different strains of Gram-positive 
bacteria (Bacillus subtilis RCMB 101-001  and Staphylococcus aureus RCMB 106-001 (1)), Gram-
negative bacteria (Pseudomonas aeruginosa RCMB 102-002 and Escherichia coli RCMB 103-001), 
yeast (Candida albicans RCMB 005003) and fungi (Aspergillus fumigates RCMB 002008 (1), 
Penicillium italicum RCMB 001018 (1) and Syncephalastrum racemosum RCMB 016001). The 
screening results revealed that all the tested compounds exhibited different inhibitory effects against 
different organisms. Thus, compounds 1, 4, exhibited inhibitory effects against all the test 
organisms, compounds 5, 7 exhibited inhibitory effects against seven of total eight test organisms, 
compound 2 exhibited inhibitory effect against six of total eight test organisms. Some tested 
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compounds, at specific concentrations, showed the same or higher inhibitory effects against some 
test organisms, compared to standard antimicrobial agents, at the same concentrations. Thus, while 
compound 1 gave the same inhibitory effect against Aspergillus fumigatus RCMB 002008 (1)        
(at concentrations 1.0, 2.5 and 5.0 mg/mL) as Tebinafine (standard antifungal agent), it showed 
much higher inhibitory effect against Syncephalastrum racemosum RCMB 016001 (at 
concentrations 2.5 and 5.0 mg/mL) and Candida albicans RCMB 005003 (at concentrations 1, 2.5 
and 5 mg/mL). Compound 7, also, compared to Terbinafine, while revealed the same inhibitory 
effect, against Penicillium italicum RCMB 001018 (1) (at concentrations 1.0, 2.5 and 5.0 mg/mL), it 
revealed higher inhibitory effect against Aspergillus fumigatus RCMB 002008 (1) (at concentration 
5.0 mg/mL), Syncephalastrum racemosum RCMB 016001 (at concentration 2.5 mg/mL) and 
Candida albicans RCMB 005003 (at concentration 5.0 mg/mL). Compared to the standard 
antibacterial Chloramphenicol, compound 7 revealed the same inhibitory effect against 
Staphylococcus aureus RCMB 106-001 (1) (at concentrations 1.0, 2.5 and 5 mg/mL) and 
Escherichia coli RCMB 103-001 (at concentrations 1.0, 2.5 and 5 mg/mL).The structure-activity 
relationship was investigated via studying the effect of the aliphatic spacer length between the two 
ethereal oxygen atoms as well as the effect of functional group attached to the two carbonyl groups 
(hydroxy/methoxy/hydrazine) on the inhibitory effect of the titled compounds. 
 
 
Keywords:  Antimicrobial activity; structure-activity relationship; 1,ω-bis(organic acids); 1,ω-bis(organic 
esters); 1,ω-bis(hydrazides); 1,ω-bis(phenoxyalkanes). 
 
1. INTRODUCTION  
 
Many Organic acids and esters  that are existed 
by nature, at different concentrations, in many 
types of foods and beverages, are potent 
antimicrobial agents and used principally in acidic 
foods as inhibitors to yeasts, molds and bacteria 
at pH above 4.5 [1]. 
 
Hydrazides and related compounds are 
described as building blocks of various 
heterocyclic rings [2] and important starting 
materials for a wide range of derivatives utilizable 
in pharmaceutical products and surfactants, so, 
they are useful medicaments, especially, in the 
treatment of inflammatory and autoimmune 
diseases, osteoarthritis, respiratory diseases, 
tumors, cachexia, cardiovascular diseases, fever, 
hemorrhage and sepsis [3]. Hydrazide derivatives 
exhibited anthelmintic [4], antifungal [5], antiviral 
[6], bacteriostatic [5-8], antiparasite [5,9], 
antituberculous [10-13], antitumor [3,14], 
anticonvulsant [15], psychotropic [5], and 
insecticidal [16] activities. While some 
heterocyclic hydrazides are useful as antifertility 
agents in rats and pigeons [17], others, find 
useful applications, as active ingredients, in 
deodorant compositions that can be used for 
removal of offensive odor [18]. 
 
Development of antibiotic-resistant bacterial and 
fungal strains over recent decades resulted in 
substantial need of new classes of antimicrobial 
agents. So, herein, and in continuation of our 
program [14,19-38] directed to synthesize and 
biologically evaluate some promising candidates  
of new organic compounds, the antimicrobial 
evaluation and structure-activity relationship of an 
interesting new class of 1,ω-bis[4-
carboxy/methoxycarbonyl/(hydrazinecarbonyl)/p-
henoxy]alkanes are studied. 
 
2. MATERIALS AND METHODS  
 
2.1 Synthesis 
 
2.1.1 General 
 
Compounds 1, 2, 4, 5, 7 (Fig. 1) were 
synthesized as reported [27] and identified by 
melting points (determined using Stuart® meting 
point apparatus SMP3 and are uncorrected), IR 
spectra (recorded in KBr discs using Perkin-
Elmer 1430 spectrometer), 1H NMR spectra 
(recorded at 300 MHz with a Varian Mercury 300 
spectrometer), mass spectra (measured on 
Shimadzu GCMS-QP2010 Plus spectrometer, 
with an EI ionization mode and 70 eV electronic 
voltage) and elemental analyses (carried out at 
the Micro Analytical Center, Cairo University, 
Giza, Egypt).  
 
2.1.2 Synthesis of 1,ω-bis(4-carboxyphenox-
y)alkanes 1, 2. General procedure [27] 
 
A mixture of each of compounds 4, 5 (5 mmol) in 
aq KOH (10%, 20 mL) was heated at reflux 
temperature for 24 h and left to cool. The non 
reacted bis(ester) was extracted with DCM          
(3 x 20 mL) and discarded. The aq phase was 
diluted with concd HCL (3-7 mL) and the
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Fig. 1. 1,ω-bis[4-carboxy/methoxycarbonyl/(hydrazinecarbonyl)/phenoxy]alkanes 
 
obtained solid was collected by filtration and 
washed successively with water (3 x 100 mL) and 
MeOH (3 x 10 mL). The product was dried and 
recrystallized from DMF/MeOH. 
 
2.1.2.1 1,2-Bis(4-carboxyphenoxy)ethane (1) 
[27] 
 
Yield 1.36 g (90%); colorless crystals, mp 350°C. 
IR: 3082-2557 (br), 3082, 2951, 2885, 2827, 
2678, 2557, 1682, 1605, 1578, 1512, 1481, 1435, 
1304, 1254, 1165, 1119, 1045, 945, 845, 768, 
691, 644, 629, 552, 505, 478, 421. 1H NMR 
(DMSO-d6) δ 4.41 (s, 4H, OCH2CH2), 7.07 (d, 4H, 
J= 8.9 Hz, ArH), 7.90 (d, 4H, J= 8.9 Hz, ArH), 
12.59 (br, 2H, D2O exchangeable OH)  Anal. 
Calcd for C16H14O6 (302.3): C, 63.57; H, 4.67. 
Found: C, 63.59; H, 4.65. 
 
2.1.2.2 1,3-Bis(4-carboxyphenoxy)propane (2) 
[27] 
 
Yield 1.38 g (87%); colorless crystals, mp 327-
328°C. Anal. Calcd for C 17H16O6 (316.3): C, 
64.55; H, 5.10. Found: C, 64.51; H, 5.18. 
 
2.1.3 Synthesis of 1,ω-bis(4-methoxycarbony-
lphenoxy)alkanes 4, 5. General 
procedure [27] 
 
To a solution of  the K-salt of methylparaben  
(100 mmol) in dry DMF (75 mL) was added 
appropriate dihalo compound (50 mmol). The 
reaction mixture was then heated at reflux 
temperature for 15 min (during which time KCl 
was separated) and poured over cold water 
containing cruched ice (150 mL). The formed 
precipitate was collected by filtration, washed 
with cold water (3 x 150 mL) followed by MeOH 
(3 x 50 mL), dried and recrystallized from 
DMF/MeOH. 
 
2.1.3.1 1,2-Bis(4-methoxycarbonylphenoxy)etha- 
ne (4) [27] 
 
Yield 4.13 g (25%); colorless crystals, mp 163-
164oC. IR: 3055, 3017, 2959, 2893, 2843, 1720, 
1609, 1508, 1481, 1435, 1346, 1315, 1254, 1215, 
1192, 1169, 1111, 1042, 1011, 953, 856, 768, 
698, 644, 517, 471, 421. 1H NMR (CDCl3) δ 3.89 
(s, 6H, COOCH3), 4.40 (s, 4H, OCH2CH2O), 6.97 
(d, 4H, J= 9.0 Hz, ArH), 8.01 (d, 4H, J= 9.0 Hz, 
ArH). Ms: m/z= 330 (M+). Anal. Calcd for 
C18H18O6 (330.3): C, 65.45; H, 5.49. Found: C, 
65.49; H, 5.38. 
 
2.1.3.2 1,3-Bis(4-methoxycarbonylphenoxy)prop- 
ane (5) [27]  
 
Yield 8.95 g (52%); colorless crystals, mp 136-
138°C. Anal. Calcd for C 19H20O6 (344.4): C, 
66.27; H, 5.85. Found: C, 66.23; H, 5.91 
 
2.1.4 Synthesis of 1,3-bis[4-(hydrazinecarbon-
yl)phenoxy]propane (7) [27] 
 
A mixture of the 1,3-bis(ester) 5 (25 mmol) and 
hydrazine monohydrate (100 mL) was heated at 
reflux temperature for 4 h during which time the 
product precipitated from the mixture. After 
cooling to room temperature, water was added 
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(100 mL) and the formed precipitate was 
collected by filtration, washed succisively with 
water (3 x 100 mL), MeOH (3 x 25 mL) and 
chloroform (3 x 25 mL), dried and recrystallized 
from DMF. Yield 7.92 g (92%); colorless crystals, 
mp 246-247°C. IR: 3298, 3275, 3186, 3071, 
2951, 2882, 1655, 1635, 1609, 1574, 1539, 1504, 
1466, 1423, 1385, 1335, 1304, 1250, 1196, 1173, 
1119, 1053, 968, 883, 849, 775, 721, 664, 625, 
521, 482, 421. 1H NMR (DMSO-d6) δ 1.88 (quint, 
2H, J= 5.3 Hz, OCH2CH2), 4.08 (t, 4H, J= 5.3 Hz, 
OCH2CH2O), 4.42 (s, 4H, D2O exchangeable 
NH2), 6.97 (d, 4H, J= 8.9 Hz, ArH), 7.79 (d, 4H, 
J= 8.9 Hz, ArH), 9.59 (s, 2H, D2O exchangeable 
NH). Anal. Calcd for C17H20N4O4 (344.4): C, 
59.29; H, 5.85; N, 16.27. Found: C, 59.22; H, 
5.79; N, 16.22. 
 
2.2 Antimicrobial Evaluation of Com-
pounds 1, 2, 4, 5, 7 
 
The in vitro antimicrobial screening of 
compounds 1, 2, 4, 5, 7 was carried out using the 
diffusion agar technique [39,40]. The test 
organisms were obtained from the culture of the 
Regional Center for Mycology and Biotechnology 
(RCMB), Faculty of Science, Al-Azhar University, 
Cairo, Egypt. Compounds 1, 2, 4, 5, 7 as well as 
standard antimicrobial agents (Chloramphenicol 
and Terbinafine were used as standard 
antibacterial and antifungal agents, respectively) 
were dissolved in DMSO (5 mg/mL). Further 
dilutions of the tested compounds and standard 
agents were prepared at the required quantities 
of 5, 2.5 and 1 mg/mL concentrations. All the 
compounds were tested for their in vitro growth 
inhibitory activity against two Gram-positive 
bacterial strains (Bacillus subtilis RCMB 101-001 
and Staphylococcus aureus RCMB 106-001 (1)), 
two Gram-negative bacterial strains 
(Pseudomonas aeruginosa RCMB 102-002 and 
Escherichia coli RCMB 103-001), one yeast 
strain (Candida albicans RCMB 005003) and 
three mould strains (Aspergillus fumigatus RCMB 
002008 (1), Penicillium italicum RCMB 001018 
(1) and Syncephalastrum racemosum RCMB 
016001). The antimicrobial activities were 
expressed as the diameter of the inhibition zones 
(Tables 1-3). 
 
3. RESULTS AND DISCUSSION 
 
Table (1) illustrates the antimicrobial activity 1,ω-
bis(4-carboxyphenoxy) alkanes (1-3). Compound 
1, namely, 1,2-bis(4-carboxyphenoxy)ethane, 
exhibited inhibitory effect against all the test 
organisms. Thus, it revealed inhibitory effects 
against Aspergillus fumigatus RCMB 002008 (1)  
(at concentrations 1.0, 2.5 and 5.0 mg/mL), 
Penicillium italicum RCMB 001018 (1) (at 
concentration 5.0 mg/mL), Syncephalastrum 
racemosum RCMB 016001 (at concentrations 2.5 
and 5.0 mg/mL), Candida albicans RCMB 
005003 (at concentrations 1.0, 2.5 and 5.0 
mg/mL), Staphylococcus aureus RCMB 106-001 
(1) (at concentration 5.0 mg/mL), Pseudomonas 
aeruginosa RCMB 102-002 (at concentrations 
2.5 and 5.0 mg/mL), Bacillus subtilis RCMB 101-
001 (at concentration 5.0 mg/mL) and 
Escherichia coli RCMB 103-001                         
(at concentrations 2.5 and 5.0 mg/mL).  
 
Compound 2, namely, 1,3-bis(4-
carboxyphenoxy)propane (Table 1), revealed 
inhibitory effect against six of total eight test 
organisms. Thus, it revealed inhibitory effects 
against Aspergillus fumigatus RCMB 002008 (1)  
(at concentrations 1.0, 2.5 and 5.0 mg/mL), 
Penicillium italicum RCMB 001018 (1) (at 
concentration 5.0 mg/mL), Candida albicans 
RCMB 005003 (at concentration 5.0 mg/mL), 
Staphylococcus aureus RCMB 106-001 (1) (at 
concentrations 1.0, 2.5 and 5.0 mg/mL), 
Pseudomonas aeruginosa RCMB 102-002 (at 
concentration 5.0 mg/mL) and Bacillus subtilis 
RCMB 101-001 (at concentrations 2.5 and 5.0 
mg/mL), while, it revealed no inhibitory effect 
against Syncephalastrum racemosum RCMB 
016001 and Escherichia coli RCMB 103-001. 
 
The antimicrobial inhibitory effect of compound 3, 
namely, 1,4-bis(4-carboxyphenoxy)butane, was 
reported [27]. Thus, Compound 3, as previously 
reported [27], against the current test organisms, 
revealed inhibitory effect against six of eight (it 
was also reported to give inhibitory effect against 
salmonella typhi at concentrations 2.5, 5.0 
mg/mL). Compound 3 revealed inhibitory effects 
against Aspergillus fumigatus RCMB 002008 (1) 
(at concentrations 1.0, 2.5 and 5.0 mg/mL), 
Syncephalastrum racemosum RCMB 016001 (at 
concentrations 1.0, 2.5 and 5.0 mg/mL), Candida 
albicans RCMB 005003 (at concentration 5.0 
mg/mL), Staphylococcus aureus RCMB 106-001 
(1) (at concentration 5.0 mg/mL), Pseudomonas 
aeruginosa RCMB 102-002 (at concentration 5.0 
mg/mL), Escherichia coli RCMB 103-001 (at 
concentration 5.0 mg/mL), while, it revealed no 
inhibitory effect against Penicillium italicum 
RCMB 001018 (1) and Bacillus subtilis RCMB 
101-001.  
 
Having shorter spacer between the aromatic 
rings, compound 1 showed much broad 
spectrum, than those of compounds 2 and 3, as it
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Table 1. Antimicrobial activity of 1,ω-bis(4-carboxyphenoxy)alkanes (1-3) compared to standard 
antimicrobial agents 
 
O
O
OH
O
O
OH
X
1-3
 
 
Test Organisms Compound 
1a 2 a 3a, d St.b St.c 
Concentration (mg/mL) 
1 2.5 5 1 2.5 5 1 2.5 5 1 2.5 5 1 2.5 5 
A. fumigatus 
RCMB 002008 (1) 
+ + + + + + + + ++ 0 0 0 + + + 
P. italicum RCMB 
001018 (1) 
0 0 + 0 0 + 0 0 0 0 + + + + + 
S. racemosum 
RCMB 016001 
0 + ++ 0 0 0 + + ++ + + + 0 0 + 
C. albicans RCMB 
005003 
+ + + 0 0 + 0 0 + 0 + + 0 0 0 
S.aureus RCMB 
106-001 (1) 
0 0 + + + + 0 0 + + + + + + ++ 
P. aeruginosa 
RCMB 102-002 
0 + + 0 0 + 0 0 + + + + 0 0 0 
B. subtilis RCMB 
101-001 
0 0 + 0 + + 0 0 0 ++ ++ ++ 0 0 + 
E. coli RCMB 103-
001 
0 + + 0 0 0 0 0 + + + + + + + 
Note: The test was done using the diffusion agar technique. Inhibition values = 0.1-0.5 cm beyond control = +; 
Inhibition values = 0.6-1.0 cm beyond control = ++; Inhibition values = 1.0-1.5 cm beyond control = +++; 0 = Not 
detected. 
a100 µL of each conc. was tested (1.0, 2.5, 5.0 mg/mL); Well diameter = 0.6 cm. 
bSt.: Reference standard; Chloramphenicol was used as a standard antibacterial agent. 
cSt.: Reference standard; Terbinafine was used as a standard antifungal agent. 
dActivity of compound 3 was reported [27] 
 
showed inhibitory effect against all the test 
organisms at concentration 5.0 mg/mL, while, 
compounds 2 and 3, with longer spacer, revealed 
inhibitory effect against six of total eight test 
organisms, at the same concentration. On the 
other hand, compound 3, with longer spacer, 
exhibited higher inhibitory effect against 
Aspergillus fumigatus RCMB 002008 (1) (at 
concentration 5.0 mg/mL) and Syncephalastrum 
racemosum RCMB 016001 (at concentration 1.0 
mg/mL). 
 
Compound 4, namely, 1,2-bis(4-
methoxycarbonylphenoxy)ethane (Table 2), 
showed inhibitory effect against all the test 
organisms. Thus, it revealed inhibitory effects 
against Aspergillus fumigatus RCMB 002008 (1) 
(at concentration 5.0 mg/mL), Penicillium italicum 
RCMB 001018 (1) (at concentration 5.0 mg/mL), 
Syncephalastrum racemosum RCMB 016001   
(at concentration 5.0 mg/mL), Candida albicans 
RCMB 005003 (at concentration 5.0 mg/mL), 
Staphylococcus aureus RCMB 106-001 (1)        
(at concentrations 2.5 and 5.0 mg/mL), 
Pseudomonas aeruginosa RCMB 102-002 (at 
concentrations 2.5 and 5.0 mg/mL),           
Bacillus subtilis RCMB 101-001                         
(at concentrations 1.0, 2.5 and 5.0 mg/mL) and 
Escherichia coli RCMB 103-001                         
(at concentrations 2.5 and 5.0 mg/mL). 
 
Compound 5, namely, 1,3-bis(4-
methoxycarbonylphenoxy)propane (Table 2), 
revealed inhibitory effect against seven of total 
eight test organisms. Thus, it revealed inhibitory 
effects against Aspergillus fumigatus RCMB 
002008 (1) (at concentration 5.0 mg/mL), 
Penicillium italicum RCMB 001018 (1) (at 
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Table 2. Antimicrobial activity of 1,ω-bis(4-methoxycarbonylphenoxy)alkanes (4-6) compared to 
standard antimicrobial agents 
 
O
O
O
O
X
OMeMeO 4-6
 
 
Test 
Organisms 
Compound 
Compound 4a Compound 5a Compound 6a,d St.b St.c 
Concentration (mg/mL) 
1 2.5 5 1 2.5 5 1 2.5 5 1 2.5 5 1 2.5 5 
A. fumigatus 
RCMB 
002008 (1) 
0 0 + 0 0 + 0 + + 0 0 0 + + + 
P. italicum 
RCMB 
001018 (1) 
0 0 + 0 + + + + + 0 + + + + + 
S. 
racemosum 
RCMB 
016001 
0 0 + + + + + + ++ + + + 0 0 + 
C. albicans 
RCMB 
005003 
0 0 + + + ++ + + ++ 0 + + 0 0 0 
S. aureus 
RCMB 106-
001 (1) 
0 + + + + + 0 + + + + + + + ++ 
P. aeruginosa 
RCMB 102-
002 
0 + + + + + 0 0 0 + + + 0 0 0 
B. subtilis 
RCMB 101-
001 
+ + ++ 0 0 0 + + + ++ ++ ++ 0 0 + 
E. coli RCMB 
103-001 
0 + + + + + 0 + ++ + + + + + + 
Note: The test was done using the diffusion agar technique. Inhibition values = 0.1-0.5 cm beyond control = +; 
Inhibition values = 0.6-1.0 cm beyond control = ++; Inhibition values = 1.0-1.5 cm beyond control = +++; 0 = Not 
detected. 
a100 µL of each conc. was tested (1.0, 2.5, 5.0 mg/mL); Well diameter = 0.6 cm. 
bSt.: Reference standard; Chloramphenicol was used as a standard antibacterial agent. 
cSt.: Reference standard; Terbinafine was used as a standard antifungal agent. 
dActivity of compound 6 was reported [27] 
 
concentrations 2.5 and 5.0 mg/mL), 
Syncephalastrum racemosum RCMB 016001 (at 
concentrations 1.0, 2.5 and 5.0 mg/mL), Candida 
albicans RCMB 005003 (at concentrations 1.0, 
2.5 and 5.0 mg/mL), Staphylococcus aureus 
RCMB 106-001 (1) (at concentrations 1.0, 2.5 
and 5.0 mg/mL), Pseudomonas aeruginosa 
RCMB 102-002 (at concentrations 1.0, 2.5 and 
5.0 mg/mL) and Escherichia coli RCMB 103-001 
(at concentrations 1.0, 2.5 and 5.0 mg/mL), while, 
it revealed no inhibitory effect against Bacillus 
subtilis RCMB 101-001. 
 
The antimicrobial inhibitory effect of compound 6, 
namely, 1,4-bis(4-methoxycarbonylphenoxy)buta- 
ane, was reported [27]. Thus, Compound 6, as 
previously reported [27], versus the current eight 
test organisms, revealed inhibitory effect against 
seven of them (it also exhibited no inhibitory 
effect against Salmonella typhi at concentrations 
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Table 3. Antimicrobial activity of 1,ω-bis[4-(hydrazinecarbonyl)phenoxy]alkanes  (7, 8) 
compared to standard antimicrobial agents 
 
O
O
NH
NH2
O
O
X
NH
NH2 7, 8
 
 
Test organisms Compound 
Compound 7a Compound 8a, d St.b St.c 
Concentration (mg/mL) 
1 2.5 5 1 2.5 5 1 2.5 5 1 2.
5 
5 
A. fumigatus 
RCMB 002008 (1) 
+ + ++ + + + 0 0 0 + + + 
P. italicum RCMB 
001018 (1) 
+ + + 0 + + 0 + + + + + 
S. racemosum 
RCMB 016001 
0 + + 0 + + + + + 0 0 + 
C. albicans  
RCMB 005003 
0 0 + ++ ++ +++ 0 + + 0 0 0 
S. aureus RCMB 
106-001 (1) 
+ + + 0 + + + + + + + ++ 
P. aeruginosa 
RCMB 102-002 
0 0 0 0 0 + + + + 0 0 0 
B. subtilis RCMB 
101-001 
0 + + + + + ++ ++ +
+ 
0 0 + 
E. coli RCMB 103-
001 
+ + + 0 + + + + + + + + 
Note: The test was done using the diffusion agar technique. Inhibition values = 0.1-0.5 cm beyond control = +; 
Inhibition values = 0.6-1.0 cm beyond control = ++; Inhibition values = 1.0-1.5 cm beyond control = +++; 0 = Not 
detected. 
a100 µL of each conc. was tested (1.0, 2.5, 5.0 mg/mL); Well diameter = 0.6 cm. 
bSt.: Reference standard; Chloramphenicol was used as a standard antibacterial agent. 
cSt.: Reference standard; Terbinafine was used as a standard antifungal agent. 
dActivity of compound 8 was reported [27] 
 
1.0, 2.5 and 5.0 mg/mL). Compound 6 revealed 
inhibitory effects against Aspergillus fumigatus 
RCMB 002008 (1) (at concentrations 2.5 and 5.0 
mg/mL), Penicillium italicum RCMB 001018 (1) 
(at concentrations 1.0, 2.5 and 5.0 mg/mL), 
Syncephalastrum racemosum RCMB 016001    
(at concentrations 1.0, 2.5 and 5.0 mg/mL),    
Candida albicans RCMB 005003 (at 
concentrations 1.0, 2.5 and 5.0 mg/mL), 
Staphylococcus aureus RCMB 106-001 (1) (at 
concentrations  2.5 and 5.0 mg/mL), Bacillus 
subtilis RCMB 101-001 at concentrations (1.0, 
2.5 and 5.0 mg/mL) and Escherichia coli RCMB 
103-001 (at concentrations 2.5 and 5.0 mg/mL), 
while, it revealed no inhibitory effect against 
Pseudomonas aeruginosa RCMB 102-002. 
 
It could be noted that, compound 4, with short 
spacer, showed much broad spectrum, than 
those of compounds 5 and 6, as it showed 
inhibitory effect against all the test organisms at 
concentration 5.0 mg/mL, while, compounds 5 
and 6, with longer spacer, revealed inhibitory 
effect against seven  of total eight test organisms. 
At concentration 5 mg/mL, compound 4, with 
short spacer, revealed its most inhibitory effect 
against Bacillus subtilis RCMB 101-001, 
compound 5, with medium spacer revealed its 
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most potent inhibitory effect against Candida 
albicans RCMB 005003, compound 6 with longer 
spacer revealed its most potent inhibitory effect 
against Syncephalastrum racemosum RCMB 
016001, Candida albicans RCMB 005003 and 
Escherichia coli RCMB 103-001. 
 
Compound 7, namely, 1,3-bis[4-
(hydrazinecarbonyl)phenoxy]propane (Table 3), 
exhibited inhibitory effect against seven of total 
eight test organisms. Thus, it revealed inhibitory 
effects against Aspergillus fumigatus RCMB 
002008 (1) (at concentrations 1.0, 2.5 and 5.0 
mg/mL), Penicillium italicum RCMB 001018 (1) 
(at concentrations 1.0, 2.5 and 5.0  mg/mL), 
Syncephalastrum racemosum RCMB 016001 (at 
concentrations 2.5 and 5.0 mg/mL), Candida 
albicans RCMB 005003 (at concentration 5.0 
mg/mL), Staphylococcus aureus RCMB 106-001 
(1) (at concentrations 1.0, 2.5 and 5.0 mg/mL), 
Bacillus subtilis RCMB 101-001 (at 
concentrations 2.5 and 5.0 mg/mL) and 
Escherichia coli RCMB 103-001 (at 
concentrations 1.0, 2.5 and 5.0 mg/mL), while, it 
revealed no inhibitory effect against 
Pseudomonas aeruginosa RCMB 102-002. 
 
Compared to the previously reported activity of 
1,4-bis[4-(hydrazinecarbonyl)phenoxy]butane 8 
[27], compound 7, with shorter spacer showed 
lower inhibitory effect against Candida albicans 
RCMB 005003 (at concentrations 1.0, 2.5 and 
5.0 mg/mL), Pseudomonas aeruginosa RCMB 
102-002 (at concentration 5.0 mg/mL) and 
Bacillus subtilis RCMB 101-001 (at concentration 
1 mg/mL). On the other hand, compound 7 gave 
higher inhibitory effect against Aspergillus 
fumigates RCMB 002008 (at concentration 5.0 
mg/mL), Penicillium italicum RCMB 001018 (1) 
(at concentration 1.0 mg/mL), Staphylococcus 
aureus RCMB 106-001 (1) (at concentration 1.0 
mg/mL) and Escherichia coli RCMB 103-001 (at 
concentration 1.0 mg/mL), compared to 
compound 8. 
 
Compared to standard antimicrobial agents, while 
some compounds, at specific concentrations 
showed the same inhibitory effect against some 
organisms, at other concentrations, they revealed 
higher inhibitory effect against other organisms. 
For example, while compound 1 gave the same 
inhibitory effect against Aspergillus fumigatus 
RCMB 002008 (1) (at concentrations 1.0, 2.5 and 
5.0 mg/mL) as Tebinafine (standard antifungal 
agent), it showed much higher inhibitory effect 
against Syncephalastrum racemosum RCMB 
016001 (at concentrations 2.5 and 5.0 mg/mL) 
and Candida albicans RCMB 005003 (at 
concentrations 1, 2.5 and 5 mg/mL). Compound 
7, also, compared to Terbinafine, while revealed 
the same inhibitory effect, against Penicillium 
italicum RCMB 001018 (1) (at concentrations 1.0, 
2.5 and 5.0 mg/mL), it revealed higher inhibitory 
effect against Aspergillus fumigatus RCMB 
002008 (1) (at concentration 5.0 mg/mL), 
Syncephalastrum racemosum RCMB 016001 (at 
concentration 2.5 mg/mL) and Candida albicans 
RCMB 005003 (at concentration 5.0 mg/mL). 
Compared to the standard antibacterial 
Chloramphenicol, compound 7 revealed the 
same inhibitory effect against Staphylococcus 
aureus RCMB 106-001 (1) (at concentrations 1.0, 
2.5 and 5 mg/mL) and Escherichia coli RCMB 
103-001 (at concentrations 1.0, 2.5 and 5 
mg/mL). 
 
4. CONCLUSION 
 
The biologically evaluated 1,ω-bis[4-carboxy/met- 
hoxycarbonyl/(hydrazinecarbonyl)/phenoxy]alka- 
nes 1, 2, 4, 5, 7 were found to possess 
antimicrobial activity against wide spread 
microorganisms (Gram-postive bacteria, Gram-
negative bacteria, yeast and fungi). The potency 
of the evaluated compounds depends on the 
functional group attached to the carbonyl ring as 
well as the spacer length between the two 
aromatic rings. Some of the evaluated 
compounds, versus some organisms, were found 
to be either as potent as or more potent than the 
standard antimicrobial agents, at specific 
concentrations. 
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